ADC Therapeutics Announces Preclinical Data Highlighted at the American Association for Cancer Research Annual Meeting 2025
Hand-out
Press Releases
ADC Therapeutics SA  
April 28, 2025

ADC Therapeutics Announces Preclinical Data Highlighted at the American Association for Cancer Research Annual Meeting 2025

Oral presentation shows ADCT-242 targeting Claudin-6 was well-tolerated and demonstrated potent

avatar profile Olean Times Herald

Olean Times Herald


Local & Social